Discover open access scientific publications

Search, annotate, share and cite publications

Publications by C. Samsonoff

Construction of Live Vaccines Using Genetically Engineered Poxviruses: Biological Activity of Vaccinia Virus Recombinants Expressing the Hepatitis B Virus Surface Antigen and the Herpes Simplex Virus Glycoprotein D.

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

1984

English

Related publications

Genetic Immunization With Adeno-Associated Virus Vectors Expressing Herpes Simplex Virus Type 2 Glycoproteins B and D.

English

Glycoprotein 110, the Epstein-Barr Virus Homolog of Herpes Simplex Virus Glycoprotein B, Is Essential for Epstein-Barr Virus Replication in Vivo.

English

Characterization of Soluble Glycoprotein D-Mediated Herpes Simplex Virus Type 1 Infection

Virology

2007

English

Herpes Simplex Virus Type 1 Glycoprotein E Domains Involved in Virus Spread and Disease

English

Evaluation of Recombinant Adenovirus Vaccines Based on Glycoprotein D and Truncated UL25 Against Herpes Simplex Virus Type 2 in Mice

Microbiology and Immunology

English

ELISA for Quantitative Determination of Hepatitis B Virus Surface Antigen

English

Functional Region IV of Glycoprotein D From Herpes Simplex Virus Modulates Glycoprotein Binding to the Herpesvirus Entry Mediator

English

Functional Analysis of the Coronavirus MHV-JHM Surface Glycoproteins in Vaccinia Virus Recombinants

Advances in Experimental Medicine and Biology

English

Immunization With DNA Vaccines Encoding Glycoprotein D or Glycoprotein B, Alone or in Combination, Induces Protective Immunity in Animal Models of Herpes Simplex Virus-2 Disease.

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

1996

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by C. Samsonoff

Construction of Live Vaccines Using Genetically Engineered Poxviruses: Biological Activity of Vaccinia Virus Recombinants Expressing the Hepatitis B Virus Surface Antigen and the Herpes Simplex Virus Glycoprotein D.

Related publications

Genetic Immunization With Adeno-Associated Virus Vectors Expressing Herpes Simplex Virus Type 2 Glycoproteins B and D.

Glycoprotein 110, the Epstein-Barr Virus Homolog of Herpes Simplex Virus Glycoprotein B, Is Essential for Epstein-Barr Virus Replication in Vivo.

Characterization of Soluble Glycoprotein D-Mediated Herpes Simplex Virus Type 1 Infection

Herpes Simplex Virus Type 1 Glycoprotein E Domains Involved in Virus Spread and Disease

Evaluation of Recombinant Adenovirus Vaccines Based on Glycoprotein D and Truncated UL25 Against Herpes Simplex Virus Type 2 in Mice

ELISA for Quantitative Determination of Hepatitis B Virus Surface Antigen

Functional Region IV of Glycoprotein D From Herpes Simplex Virus Modulates Glycoprotein Binding to the Herpesvirus Entry Mediator

Functional Analysis of the Coronavirus MHV-JHM Surface Glycoproteins in Vaccinia Virus Recombinants

Immunization With DNA Vaccines Encoding Glycoprotein D or Glycoprotein B, Alone or in Combination, Induces Protective Immunity in Animal Models of Herpes Simplex Virus-2 Disease.